Skip to main content

Clinical Neuroimmunology

The group of Clinical Neuroimmunology - Centre d'Esclerosi Múltiple de Catalunya (Cemcat) at the Vall d'Hebron Institut de Recerca (VHIR) is a multidisciplinary group dedicated to clinical assistance, physical and cognitive rehabilitation, and clinical and basic research on multiple sclerosis (MS). Cemcat is a national but also an international reference center in the clinical assistance of MS patients. The research performed in the group is divided and further combined in clinical and basic research. In addition, basic research has a marked translational character since the ultimate goal of the group is to improve the quality of life of patients suffering from MS, through in-depth knowledge of the pathogenic mechanisms of the disease and the development of new and more effective therapeutic approaches. 

Publications

MRI as a biomarker of the smouldering component of multiple sclerosis: time to wake up.

PMID: 37973633
Journal: EUROPEAN RADIOLOGY
Year: 2023
Reference: Eur Radiol. 2023 Nov 16. doi: 10.1007/s00330-023-10416-6.
Impact factor:
Publication type: Editorail in international publication
Authors: Arntzen, Ellen Christin; Coote, Susan; Jonsdottir, Johanna; Kalron, Alon; Kos, Daphne; Learmonth, Yvonne C; Moumdjian, Lousin; Nedeljkovic, Una; Novotna, Klara; Pareto, Deborah et al.
DOI: 10.1007/s00330-023-10416-6

Rare Genomic Copy Number Variants Implicate New Candidate Genes for Bicuspid Aortic Valve.

PMID: 37961530
Journal:
Year: 2023
Reference: medRxiv. 2023 Oct 24:2023.10.23.23297397. doi: 10.1101/2023.10.23.23297397. Preprint.
Impact factor:
Publication type: Other (letters to the editor, abstracts, corrigendum, etc.)
Authors: Albasha, Hasan; Alexandri, Nektaria; Andreassi, Maria Grazia; Bianco, Lisa; Bissell, Malenka M; Body, Simon C; Brieva, Luis; Brochet, Bruno; Caffarelli, Anthony; Carlisle, Steven G et al.
DOI: 10.1101/2023.10.23.23297397

A Phase I/II Study of GSK525762 Combined With Fulvestrant in Patients With Hormone Receptor-Positive/HER2-Negative (HR+/HER2-) Advanced or Metastatic Breast Cancer.

PMID: 37992310
Journal: CLINICAL CANCER RESEARCH
Year: 2023
Reference: Clin Cancer Res. 2023 Nov 22. doi: 10.1158/1078-0432.CCR-23-0133.
Impact factor:
Publication type: Paper in international publication
Authors: Abdel-Mannan, Omar; Barbash, Olena; Cescon, David W; Champsas, Dimitrios; Chitre, Manali; Ciccarelli, Olga; Desai, Ishita; Dhar, Arindam; Forsyth, Rob; Hacohen, Yael et al.
DOI: 10.1158/1078-0432.CCR-23-0133

Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.

PMID: 38033284
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2023
Reference: J Clin Oncol. 2023 Nov 30:JCO2300897. doi: 10.1200/JCO.23.00897.
Impact factor:
Publication type: Paper in international publication
Authors: Abdalkader, Mohamad; Bautista Sirvent, Francisco J; Bertrand, Yves; Beverloo, Berna H; Bourquin, Jean-Pierre; Brivio, Erica; Bui, Jenny; Bukowinski, Andrew; Cooper, Stacy; de Havenon, Adam et al.
DOI: 10.1200/JCO.23.00897

Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.

PMID: 36001711
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Year: 2022
Reference: N Engl J Med. 2022 Aug 25;387(8):704-714. doi: 10.1056/NEJMoa2201904.
Impact factor:
Publication type: Paper in international publication
Authors: Adamczyk-Sowa, Monika; Alekseenko, Yuri; Alifirova, Valentina; Alvarez, Enrique; Alvarez, Enrique; Arefyeva, Elena; Arroyo Gonzalez, Rafael; Bakhtiyarova, Klara; Belova, Anna; Bernitsas, Evanthia et al.
DOI: 10.1056/NEJMoa2201904

[Epidemiology of neuromyelitis optica spectrum. New and old challenges].

PMID: 34927702
Journal: REVISTA DE NEUROLOGIA
Year: 2022
Reference: Rev Neurol. 2022 Jan 1;74(1):22-34. doi: 10.33588/rn.7401.2021163.
Impact factor: 0.87
Publication type: Review in national publication
Authors: Sepulveda, M; Arrambide, G; Cobo-Calvo, A et al.
DOI: 10.33588/rn.7401.2021163

Charting a global research strategy for progressive MS-An international progressive MS Alliance proposal.

PMID: 34850641
Journal: Multiple Sclerosis Journal
Year: 2022
Reference: Mult Scler. 2022 Jan;28(1):16-28. doi: 10.1177/13524585211059766. Epub 2021 Dec 1.
Impact factor: 6.312
Publication type: Paper in international publication
Authors: Coetzee, Timothy; Zaratin, Paola; Strum, Jon; Smith, Kathryn E; Thompson, Alan J; Carroll, William; Ciccarelli, Olga; Comi, Giancarlo; Cross, Anne; Donnelly, Alexis et al.
DOI: 10.1177/13524585211059766

Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis survey.

PMID: 33764197
Journal: Multiple Sclerosis Journal
Year: 2022
Reference: Mult Scler. 2022 Jan;28(1):132-138. doi: 10.1177/13524585211005339. Epub 2021 Mar 25.
Impact factor: 6.312
Publication type: Paper in international publication
Authors: Portaccio, Emilio; Fonderico, Mattia; Hemmer, Bernhard; Derfuss, Tobias; Stankoff, Bruno; Selmaj, Krzysztof; Tintore, Mar; Amato, Maria Pia et al.
DOI: 10.1177/13524585211005339

Chitinase 3-like 1 is not a target antigen in patients with multiple sclerosis.

PMID: 33327838
Journal: Multiple Sclerosis Journal
Year: 2021
Reference: Mult Scler. 2021 Aug;27(9):1455-1457. doi: 10.1177/1352458520980141. Epub 2020 Dec 17.
Impact factor: 6.312
Publication type: Paper in international publication
Authors: Comabella, Manuel, Deutschmann, Claudia, Midaglia, Luciana, Schierack, Peter, Martinez, Julia, Roggenbuck, Dirk, Montalban, Xavier et al.
DOI: 10.1177/1352458520980141

Direct to Angiography Suite Without Stopping for Computed Tomography Imaging for Patients With Acute Stroke: A Randomized Clinical Trial.

PMID: 34338742
Journal: JAMA Neurology
Year: 2021
Reference: JAMA Neurol. 2021 Sep 1;78(9):1099-1107. doi: 10.1001/jamaneurol.2021.2385.
Impact factor: 18.302
Publication type: Paper in international publication
Authors: Requena, Manuel, Olive-Gadea, Marta, Muchada, Marian, Hernandez, David, Rubiera, Marta, Boned, Sandra, Pinana, Carlos, Deck, Matias, Garcia-Tornel, Alvaro, Diaz-Silva, Humberto et al.
DOI: 10.1001/jamaneurol.2021.2385

Multiple sclerosis is associated with higher comorbidity and healthcare resource use: a population-based, case-control study in a western Mediterranean region.

PMID: 34293826
Journal: EUROPEAN JOURNAL OF NEUROLOGY
Year: 2021
Reference: Eur J Neurol. 2021 Dec;28(12):4124-4134. doi: 10.1111/ene.15030. Epub 2021 Aug 5.
Impact factor: 6.089
Publication type: Paper in international publication
Authors: Cardenas-Robledo, Simon, Otero-Romero, Susana, Passarell-Bacardit, Maria Angels, Carbonell-Mirabent, Pere, Sastre-Garriga, Jaume, Montalban, Xavier, Tintore, Mar et al.
DOI: 10.1111/ene.15030

Cortical metabolic and structural differences in patients with chronic migraine. An exploratory (18)FDG-PET and MRI study.

PMID: 34273945
Journal: JOURNAL OF HEADACHE AND PAIN
Year: 2021
Reference: J Headache Pain. 2021 Jul 17;22(1):75. doi: 10.1186/s10194-021-01289-5.
Impact factor: 7.277
Publication type: Paper in international publication
Authors: Torres-Ferrus, Marta, Pareto, Deborah, Gallardo, Victor J, Cuberas-Borros, Gemma, Alpuente, Alicia, Caronna, Edoardo, Vila-Ballo, Adria, Lorenzo-Bosquet, Carles, Castell-Conesa, Joan, Rovira, Alex et al.
DOI: 10.1186/s10194-021-01289-5

The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MS.

PMID: 31610739
Journal: Multiple Sclerosis Journal
Year: 2020
Reference: Mult Scler. 2020 Nov;26(13):1658-1669. doi: 10.1177/1352458519877810. Epub 2019 Oct 15.
Impact factor: 5.649
Publication type: Paper in international publication
Authors: Arevalo, Maria Jesus, Anglada, Elisenda, Menendez, Rebeca, Midaglia, Luciana, Galan, Ingrid, Vidal-Jordana, Angela, Castillo, Joaquin, Mulero, Patricia, Zabalza, Ana, Rodriguez-Acevedo, Breogan et al.
DOI: 10.1177/1352458519877810

COVID-19 and Stroke: Incidence and Etiological Description in a High-Volume Center.

PMID: 33066917
Journal: Journal of Stroke & Cerebrovascular Diseases
Year: 2020
Reference: J Stroke Cerebrovasc Dis. 2020 Nov;29(11):105225. doi: 10.1016/j.jstrokecerebrovasdis.2020.105225. Epub 2020 Aug 5.
Impact factor: 1.787
Publication type: Paper in international publication
Authors: Ribo, Marc, Molina, Carlos A, Tomasello, Alejandro, Rubiera, Marta, Requena, Manuel, Muchada, Marian, Garcia-Tornel, Alvaro, Deck, Matias, Juega, Jesus, Boned, Sandra et al.
DOI: 10.1016/j.jstrokecerebrovasdis.2020.105225

Purified IgG from aquaporin-4 neuromyelitis optica spectrum disorder patients alters blood-brain barrier permeability.

PMID: 32881954
Journal: PLoS One
Year: 2020
Reference: PLoS One. 2020 Sep 3;15(9):e0238301. doi: 10.1371/journal.pone.0238301. eCollection 2020.
Impact factor: 2.74
Publication type: Paper in international publication
Authors: Cobo-Calvo, Alvaro, Ruiz, Anne, Richard, Chloe, Blondel, Sandrine, Cavagna, Sylvie, Strazielle, Nathalie, Ghersi-Egea, Jean-Francois, Giraudon, Pascale, Marignier, Romain et al.
DOI: 10.1371/journal.pone.0238301

Relationship of estrogen synthesis capacity in the brain with obesity and self-control in men and women.

PMID: 32868418
Journal: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Year: 2020
Reference: Proc Natl Acad Sci U S A. 2020 Sep 15;117(37):22962-22966. doi: 10.1073/pnas.2006117117. Epub 2020 Aug 31.
Impact factor: 9.412
Publication type: Paper in international publication
Authors: Biegon, Anat, Alia-Klein, Nelly, Alexoff, David L, Fowler, Joanna S, Kim, Sung Won, Logan, Jean, Pareto, Deborah, Preston-Campbell, Rebecca, Wang, Gene-Jack, Hildebrandt, Tom et al.
DOI: 10.1073/pnas.2006117117

Classic Block Design "Pseudo"-Resting-State fMRI Changes After a Neurorehabilitation Program in Patients with Multiple Sclerosis.

PMID: 29400912
Journal: JOURNAL OF NEUROIMAGING
Year: 2018
Reference: J Neuroimaging. 2018 May;28(3):313-319. doi: 10.1111/jon.12500. Epub 2018 Feb 5.
Impact factor: 1.953
Publication type: Paper in international publication
Authors: Rovira, Alex, Renom, Marta, Pareto, Deborah, Sastre-Garriga, Jaume, Alonso, Juli, Galan, Ingrid, Arevalo, Maria Jesus, Montalban, Xavier et al.
DOI: 10.1111/jon.12500

Correction to: Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.

PMID: 29177546
Journal: JOURNAL OF NEUROLOGY
Year: 2018
Reference: J Neurol. 2018 Jan;265(1):32. doi: 10.1007/s00415-017-8679-5.
Impact factor: 3.783
Publication type: Letter or abstract
Authors: Alenda, Raquel, Costa-Frossard, Lucienne, Alvarez-Lafuente, Roberto, Espejo, Carmen, Rodriguez-Martin, Eulalia, Sainz de la Maza, Susana, Villarrubia, Noelia, Rio, Jordi, Dominguez-Mozo, Maria I, Alvarez-Cermeno, Jose C et al.
DOI: 10.1007/s00415-017-8679-5

Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.

PMID: 29027004
Journal: JOURNAL OF NEUROLOGY
Year: 2018
Reference: J Neurol. 2018 Jan;265(1):24-31. doi: 10.1007/s00415-017-8625-6. Epub 2017 Oct 12.
Impact factor: 3.783
Publication type: Paper in international publication
Authors: Villar, Luisa M, Alvarez-Cermeno, Jose C, Montalban, Xavier, Dominguez-Mozo, Maria I, Alenda, Raquel, Costa-Frossard, Lucienne, Alvarez-Lafuente, Roberto, Espejo, Carmen, Rodriguez-Martin, Eulalia, de la Maza, Susana Sainz et al.
DOI: 10.1007/s00415-017-8625-6

[Rituximab: its efficacy, effectiveness and safety in the treatment of multiple sclerosis].

PMID: 29251340
Journal: REVISTA DE NEUROLOGIA
Year: 2018
Reference: Rev Neurol. 2018 Jan 1;66(1):25-32.
Impact factor: 0.601
Publication type: Review in national publication
Authors: Midaglia, L, Mora, L, Mulero, P, Sastre-Garriga, J, Montalban, X et al.
DOI: 10.33588/rn.6601.2017213

Blog

News

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

Dr. Carmen Espejo and Dr. Georgina Arrambide, researchers at Cemcat and Vall d'Hebron Research Institute, are the first authors of the article.

The research findings propose to modify the McDonald 2017 criteria, only in those in whom diagnosis using the current criteria is not possible.

Rates

Simoa HD1 equipment

We are seeking healthy volunteers for a study to find biomarkers of multiple sclerosis

We are looking for 100 healthy volunteers aged 18 or over to participate in a project where the usefulness of biomarkers in serum will be evaluated to predict the prognosis of the disease and the response to treatments.

More information